RxDoctor Payments Data

Erika Kuhn, APRN

Nurse Practitioner · Greeley, CONPI 1861158347

Payments from drug & device makers

$1,810in general payments, 2019–2025

Across 96 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$304
  • AbbVie$288
  • Lilly USA, LLC$247
  • AstraZeneca$166
  • Biohaven Pharmaceutical Holding Company Ltd.$150
  • Novo Nordisk$146
  • plus $509 from 10 others

What the payments were for

  • Food & beverage$1,810100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,810 in reported general payments places this provider in the 85th percentile of 1,384 nurse practitioner providers in Colorado.

See all nurse practitioner providers in Colorado

Medicare billing

Part B allowed, 2024
$19,224
Medicare patients
85
Services billed
426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide36$47,279
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$14,545
Albuterol Sulfate HfaAlbuterol Sulfate47$1,336
Gabapentin41$916
Omeprazole26$715
Metformin Hcl57$590
Atorvastatin Calcium102$482
Tamsulosin Hcl29$336
Dutasteride11$333
Fluticasone Propionate14$324
Levothyroxine Sodium40$302
Lisinopril59$271
Alendronate Sodium12$230
Famotidine11$227
Losartan Potassium33$189

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$247$47,27936 claims
AstraZenecaBreztri Aerosphere$166$14,54520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,384 nurse practitioner providers in Colorado.

Other nurse practitioner in Greeley

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →